Orgenesis Corp (ORGS) - Market Capitalization

Orgenesis Inc. (ORGS) relies on external cloud resources and partner outsourcing to rapidly expand its biomedical services network. This price chart, where the market capitalization stands at 0.01, complements data regarding the creation of decentralized software and OCGM mobile systems for gene therapy. The business is currently shifting its strategic direction by implementing automated IT modules directly into medical centers to organize contract manufacturing.

ORGS orgenesis.com: Market Capitalization in the range 07/04/2022 - 10/26/2024

Analytical breakdowns for Orgenesis Corporation (ORGS)

- market price and analyst price targets:

Price Chart Orgenesis|ORGS - Fair Value Consensus

- market capitalization indicators:

Market Capitalization Orgenesis Corporation|ORGS - Full Takeover Company Value

- issuer book value statistics:

Net Assets per Single Share Orgenesis|ORGS - Book Valuation of Business|Market Capitalization to Book Value Ratio orgenesis.com|ORGS - Company Total Asset Base

- debt and liquidity details:

- business earnings and investment ratios data:

ORGS - Company Profit|Expected Profit Orgenesis Inc.|ORGS - Market Cap to Earnings|Future Price to Earnings Orgenesis Corp|ORGS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Orgenesis Corporation|ORGS - Operating profit before depreciation charges|Net earnings per share (EPS TTM) Orgenesis|ORGS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months orgenesis.com|ORGS - Earnings per share growth this year|Earnings growth forecast for next year Orgenesis Inc.

Summary company analysis:ORGS (Orgenesis)

The business model of Orgenesis Inc. (ORGS) relies on a sustainable cell therapy niche with a long-term planning horizon. Market capitalization is the product of the current share price and the total number of outstanding securities. This metric determines the aggregate market value of the business, allowing for an assessment of the issuer's scale relative to its competitors. It is critical for investors to correlate valuation trends with the company's financial strength. By analyzing the public capitalization chart of Orgenesis Inc. (ORGS), one can identify stages of asset overvaluation or undervaluation.

Competitors of Orgenesis Inc. (ORGS)